Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

LENALIMID lenalidomide 5 mg capsule blister pack (307066)

ARTG ID

307066

ARTG Name

LENALIMID lenalidomide 5 mg capsule blister pack

Sponsor

Cipla Australia Pty Ltd

ARTG Date

October 8, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Cipla Australia Pty Ltd

Sponsor Item Name

CIPLA AUSTRALIA PTY LTD

Active Ingredients

Ingredient Name

lenalidomide

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

LENALIMID lenalidomide 5 mg capsule blister pack (307066) - TGA 批准文号 | MedPath